On Christmas Eve it was announced that Boston Scientific has agreed to pay $22 million as it settles claims that one of its divisions gave kickbacks to doctors.
Wendy Wysong, partner at Clifford Chance US LLP, discusses why health care providers should be critically reviewing their longstanding financial relationships to ensure compliance with recent revisions to the Stark and the Anti-Kickback laws.
Eric McClafferty, export compliance and international trade regulation partner at Kelley Drye & Warren LLP, examines important FCPA compliance and export compliance keys for health industry companies.
By Joel Hesch, Liberty University
The government has honed in on three primary areas where it alleges that a pharmaceutical company commits fraud. In addition, there is an emerging new area, adulterated products, where the DOJ is beginning to investigate and just may be the next huge compliance risk.
In today’s GRC news roundup, we link out to a story on health care organizations being to told to update anti-fraud compliance programs as well as the resurfacing a few now-notorious former Lehman execs, among others.
In today’s roundup, we offer links to the recent approval by Wyeth shareholders of the Pfizer takeover, corporate governance in times of crisis, and Andrew Cuomo’s intentions to sue Schwab for fraud over ARS.
Dr. Timothy Kuklo, currently of Washington University and formerly an Army surgeon, is accused of accepting nearly $800,000 from Medtronic and then falsifying research about some of the company’s major products.
by Tina Williamson — Director of Corporate Compliance for Mississippi Children’s Home Services
Most of your effectiveness as a compliance professional can be directly tied to the all those years of clinical experience you gained while working as a medical professional. However, you can’t reap the benefits of this experience until you learn how to channel your clinical experience in relevant ways into your new career in corporate compliance.
Making the transition from the clinical field to corporate compliance is not an easy one. Nevertheless, a compliance professional with a clinical background will find that the skills gained over the years “in the trenches” will serve them well, not only in gaining “street cred” with employees but also in developing a corporate compliance program that is easy to understand and effective.
A Fortune 500 healthcare products company is seeking an experienced JD and compliance professional to fill its opening for a Director of Global Compliance, with a full relocation package provided upon hiring.
WellCare fraud update: WellCare Health Plans Inc., a Tampa-based managed care company, has agreed to pay an $80M settlement. WellCare defrauded the Florida Medicaid program and Florida Healthy Kids Corporation.
